Just - Evotec Biologics
Seattle
About Just - Evotec Biologics
Just Evotec Biologics was founded in 2014 and acquired by Evotec in 2019. The company has an intense focus on the design of innovative and integrated technologies to accelerate the development of biotherapeutics and reduce their manufacturing cost. Core strengths include antibody discovery, molecular design, process and product design and manufacturing plant design.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 251 – 500
- Estimated revenue: $1K – $10K
- Total funding: $162.6M
- Funding stage: M&A
- Last round: Grant (Jan 2026)
- Website: justbiotherapeutics.com
- Phone: 206.651.5094
Industries & Categories
Biopharma, Biotechnology, Health Care, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/just-evotec-biologics-30276 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.